CTOs on the Move

Secura Bio

www.securabio.com

 
Secura Bio™ is a pharmaceutical company committed to giving patients access to innovative therapies. Headquartered in Henderson, Nevada, Secura Bio™ has operations in the U.S. and Offices in San Diego.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.securabio.com
  • 1887 Whitney Mesa Drive #1050
    Henderson, NV USA 89014
  • Phone: 858.251.1414

Executives

Name Title Contact Details

Funding

Secura Bio raised $55M on 03/05/2019
Secura Bio raised $90M on 03/05/2019

Similar Companies

Pharma-Logic Development

Pharma-Logic Development is a San Rafael, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Security Card Company

Medical Security Card Company is a Tucson, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mission Cancer + Blood

As you or a loved one fight the unimaginable, we are right by your side, and right next door. Mission is a community-based healthcare team...

Tanner Pharma

For over 18 years, Tanner Pharma Group has provided highly specialized pharmaceutical services to its partners around the world. Leading pharmaceutical and biotech companies partner with Tanner Pharma to license and commercialize their products in challenging international markets, develop and manage their Global Access Programmes, and source comparator drugs for clinical trials and bioanalysis. By partnering with Tanner Pharma, manufacturers are able to focus on their primary markets and strategies while ensuring that the services they need will follow a strictly controlled protocol of quality. Headquartered in the U.S. with offices in London, São Paulo and Mexico City, Tanner Pharma Group`s reach includes Europe, Asia, the Middle East, Australia, Canada and Latin America. We measure our value as a company based on the lives we help to improve. For all of us involved in the pharmaceutical supply chain - manufacturers, distributors, pharmacists, doctors, and others - it is ultimately the patient that matters most. Therefore, we start each day with a renewed commitment to ethically supply unlicensed medicines to markets where access continues being a challenge.

Xenocor

Bringing to market revolutionary laparoscopic technologies which extend the benefits of minimally invasive surgery to hundreds of millions of people worldwide.